Lyell Immunopharma, Inc. - LYEL
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Oct 13, 2026 | Chief Medical Officer | S | D | 422.0 | 8.63 | 3,641.86 | 19,857.0 | View | |
| Sep 10, 2026 | Chief Medical Officer | A | A | 47,500.0 | 0.0 | 0.0 | 47,500.0 | View | |
| Sep 10, 2026 | Chief Medical Officer | S | D | 500.0 | 12.7 | 6,350.0 | 20,423.0 | View | |
| Aug 25, 2026 | President and CEO | S | D | 9,589.0 | 15.54 | 149,013.06 | 63,899.0 | View | |
| Aug 25, 2026 | Chief Operating Officer | S | D | 989.0 | 15.54 | 15,369.06 | 16,816.0 | View | |
| Aug 25, 2026 | Chief Scientific Officer | S | D | 1,457.0 | 15.54 | 22,641.78 | 16,220.0 | View | |
| Aug 11, 2026 | VP, Corporate Controller | S | D | 621.0 | 14.34 | 8,905.14 | 14,799.0 | View | |
| Aug 11, 2026 | Chief Scientific Officer | S | D | 131.0 | 14.34 | 1,878.54 | 17,677.0 | View | |
| Aug 11, 2026 | Chief Operating Officer | S | D | 89.0 | 14.34 | 1,276.26 | 17,805.0 | View | |
| Aug 11, 2026 | President and CEO | S | D | 390.0 | 14.34 | 5,592.6 | 73,488.0 | View | |
| Jul 27, 2026 | — | J | D | 44,000.0 | 0.0 | 0.0 | 2,774,980.0 | View | |
| Jul 27, 2026 | — | J | D | 38,500.0 | 0.0 | 0.0 | 2,818,980.0 | View | |
| Jul 20, 2026 | — | S | D | 10.0 | 13.7 | 137.0 | 2,857,480.0 | View | |
| Jul 17, 2026 | — | S | D | 10.0 | 13.73 | 137.3 | 2,857,490.0 | View | |
| Jul 01, 2026 | — | J | D | 76,000.0 | 0.0 | 0.0 | 2,857,500.0 | View | |
| Jun 18, 2026 | — | J | D | 66,500.0 | 0.0 | 0.0 | 2,933,500.0 | View | |
| Jun 15, 2026 | Chief Scientific Officer | S | D | 130.0 | 18.92 | 2,459.6 | 17,808.0 | View | |
| Jun 15, 2026 | Chief Operating Officer | S | D | 89.0 | 18.92 | 1,683.88 | 17,894.0 | View | |
| Jun 15, 2026 | VP, Corporate Controller | S | D | 217.0 | 18.91 | 4,103.47 | 15,420.0 | View | |
| Jun 15, 2026 | President and CEO | S | D | 388.0 | 18.91 | 7,337.08 | 73,878.0 | View | |
| Jun 12, 2026 | — | A | A | 9,250.0 | 0.0 | 0.0 | 9,250.0 | View | |
| Jun 12, 2026 | — | A | A | 9,250.0 | 0.0 | 0.0 | 9,250.0 | View | |
| Jun 12, 2026 | — | A | A | 9,250.0 | 0.0 | 0.0 | 9,250.0 | View | |
| Jun 12, 2026 | — | A | A | 9,250.0 | 0.0 | 0.0 | 9,250.0 | View | |
| Jun 12, 2026 | — | A | A | 9,250.0 | 0.0 | 0.0 | 9,250.0 | View | |
| Jun 12, 2026 | — | A | A | 9,250.0 | 0.0 | 0.0 | 9,250.0 | View | |
| Jun 12, 2026 | — | A | A | 9,250.0 | 0.0 | 0.0 | 9,250.0 | View | |
| Jun 11, 2026 | Chief Medical Officer | S | D | 1,977.0 | 12.64 | 24,989.28 | 20,923.0 | View |